S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
S&P 500   3,819.83 (-1.30%)
DOW   31,272.44 (-0.38%)
QQQ   310.14 (-2.59%)
AAPL   122.59 (-2.02%)
MSFT   227.80 (-2.60%)
FB   256.48 (-0.97%)
GOOGL   2,018.92 (-2.21%)
TSLA   657.50 (-4.22%)
AMZN   3,015.43 (-2.56%)
NVDA   513.69 (-4.21%)
BABA   236.24 (+0.78%)
CGC   33.31 (-5.50%)
GE   13.52 (+4.16%)
MU   89.80 (-1.42%)
NIO   41.23 (-4.76%)
AMD   81.23 (-3.45%)
T   28.80 (+2.06%)
F   12.23 (-2.55%)
ACB   10.46 (-5.17%)
DIS   193.00 (-0.48%)
BA   229.25 (+2.74%)
NFLX   522.73 (-4.58%)
PFE   34.34 (+2.48%)
Log in
NASDAQ:IOSP

Innospec Stock Forecast, Price & News

$101.20
+1.00 (+1.00 %)
(As of 03/3/2021 03:51 PM ET)
Add
Compare
Today's Range
$100.23
Now: $101.20
$102.80
50-Day Range
$87.79
MA: $97.18
$104.77
52-Week Range
$56.71
Now: $101.20
$105.50
Volume6,790 shs
Average Volume99,223 shs
Market Capitalization$2.49 billion
P/E Ratio67.92
Dividend Yield1.02%
Beta1.34
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It operates through Fuel Specialties, Performance Chemicals, and Oilfield Services segments. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and maintain asset integrity. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Innospec logo

Headlines

Innospec: Q4 Earnings Insights
February 16, 2021 |  finance.yahoo.com
Innospec's Earnings: A Preview
February 15, 2021 |  finance.yahoo.com
IOSP Feb 2021 90.000 call
February 7, 2021 |  uk.finance.yahoo.com
Is Innospec (IOSP) a Profitable Stock to Pick Right Now?
December 23, 2020 |  finance.yahoo.com
Is IOSP A Good Stock To Buy Now According To Hedge Funds?
December 18, 2020 |  finance.yahoo.com
IOSP Crosses Above Key Moving Average Level
November 9, 2020 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554
Employees1,900
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.51 billion
Cash Flow$7.39 per share
Book Value$37.51 per share

Profitability

Net Income$112.20 million

Miscellaneous

Market Cap$2.49 billion
Next Earnings Date5/4/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.82 out of 5 stars

Basic Materials Sector

63rd out of 834 stocks

Chemicals & Allied Products Industry

6th out of 30 stocks

Analyst Opinion: 1.5Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$101.20
+1.00 (+1.00 %)
(As of 03/3/2021 03:51 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Innospec (NASDAQ:IOSP) Frequently Asked Questions

Is Innospec a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Innospec stock.
View analyst ratings for Innospec
or view top-rated stocks.

What stocks does MarketBeat like better than Innospec?

Wall Street analysts have given Innospec a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Innospec wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Innospec?

Innospec saw a drop in short interest in January. As of January 15th, there was short interest totaling 360,600 shares, a drop of 20.9% from the December 31st total of 455,800 shares. Based on an average daily volume of 120,400 shares, the short-interest ratio is currently 3.0 days. Currently, 1.5% of the shares of the stock are sold short.
View Innospec's Short Interest
.

When is Innospec's next earnings date?

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Innospec
.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) announced its quarterly earnings results on Tuesday, February, 16th. The specialty chemicals company reported $1.27 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.49. Innospec had a trailing twelve-month return on equity of 9.14% and a net margin of 2.92%.
View Innospec's earnings history
.

How has Innospec's stock price been impacted by COVID-19 (Coronavirus)?

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, IOSP shares have increased by 41.6% and is now trading at $102.60.
View which stocks have been most impacted by COVID-19
.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a quarterly dividend on Tuesday, November 3rd. Stockholders of record on Tuesday, November 17th will be paid a dividend of $0.52 per share on Wednesday, November 25th. This represents a $2.08 annualized dividend and a dividend yield of 2.03%. The ex-dividend date of this dividend is Monday, November 16th.
View Innospec's dividend history
.

Is Innospec a good dividend stock?

Innospec pays an annual dividend of $1.04 per share and currently has a dividend yield of 1.02%. The dividend payout ratio of Innospec is 19.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Innospec will have a dividend payout ratio of 23.91% next year. This indicates that Innospec will be able to sustain or increase its dividend.
View Innospec's dividend history.

What price target have analysts set for IOSP?

1 Wall Street analysts have issued 1-year target prices for Innospec's shares. Their forecasts range from $110.00 to $110.00. On average, they expect Innospec's share price to reach $110.00 in the next year. This suggests a possible upside of 7.2% from the stock's current price.
View analysts' price targets for Innospec
or view top-rated stocks among Wall Street analysts.

Who are Innospec's key executives?

Innospec's management team includes the following people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 56, Pay $2.85M)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 55, Pay $798.59k)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 62, Pay $794.2k)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 72, Pay $563.43k)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 62, Pay $624.25k)
  • Mr. Graeme Blair, Head of Group Fin. (Age 38)
  • Mr. David B. Jones, VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. (Age 52)
  • Dr. Catherine Hessner, Sr. VP of HR (Age 62)
  • Mr. Thomas C. Entwistle, Pres of Oilfield Services - Americas
  • Mr. Steven W. Williams, Exec. Director (Age 65)

What is Patrick S. Williams' approval rating as Innospec's CEO?

12 employees have rated Innospec CEO Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among Innospec's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), The Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

Who are Innospec's major shareholders?

Innospec's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.64%), Wells Fargo & Company MN (8.57%), Dimensional Fund Advisors LP (5.03%), Royce & Associates LP (3.62%), Janus Henderson Group PLC (3.28%) and Alliancebernstein L.P. (2.51%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, Hugh Aldous, Ian Cleminson, Patrick Williams, Philip Curran and Philip John Boon.
View institutional ownership trends for Innospec
.

Which institutional investors are selling Innospec stock?

IOSP stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Russell Investments Group Ltd., Public Employees Retirement System of Ohio, Squarepoint Ops LLC, Barclays PLC, State of Wisconsin Investment Board, Citigroup Inc., and Northern Trust Corp. Company insiders that have sold Innospec company stock in the last year include Catherine Hessner, and Patrick Williams.
View insider buying and selling activity for Innospec
or view top insider-selling stocks.

Which institutional investors are buying Innospec stock?

IOSP stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Norges Bank, Wells Fargo & Company MN, Royce & Associates LP, BlackRock Inc., Nuveen Asset Management LLC, Janus Henderson Group PLC, and Tygh Capital Management Inc..
View insider buying and selling activity for Innospec
or or view top insider-buying stocks.

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $102.60.

How much money does Innospec make?

Innospec has a market capitalization of $2.52 billion and generates $1.51 billion in revenue each year. The specialty chemicals company earns $112.20 million in net income (profit) each year or $5.22 on an earnings per share basis.

How many employees does Innospec have?

Innospec employs 1,900 workers across the globe.

What is Innospec's official website?

The official website for Innospec is www.innospecinc.com.

Where are Innospec's headquarters?

Innospec is headquartered at 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]


This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.